Graduated in Biological Sciences Medical Modality from Universidade Estadual Paulista Júlio de Mesquita Filho - UNESP (2000), MSc degree (2003) and Ph.D. (2007) in Medical Sciences from the Faculty of Medicine of the University of São Paulo - USP - Ribeirão Preto - SP. She is currently coordinator of the Graduate Program in Biomedical Engineering at the University of Vale do Paraíba - UNIVAP - São José dos Campos - SP and leads the FOTOBIOS (Photobiology applied to Health) lab, a research group in which aim is to evaluate cellular, biochemical and molecular mechanisms and events in photobiomodulation and photodynamic therapy (PDT). She has experience in the area of Biophysics, with an emphasis on Radiology and Photobiology, working mainly in Photodynamic Therapy, Cancer, Microbiology, Parasitology, Photosensitizers and Spectroscopy. Catarina´s mother (8 years old). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The Leshmaniasis are infectious diseases caused by protozoa of the genus Leishmania that have two evolutionary forms: one flagellated form or promastigote, responsible for the infection and a unflagellated form or the amastigote form of the parasite that multiplies in the vertebrate host. The disease can manifest itself in cutaneous forms, mucocutaneous or visceral, the last being the mos…
Leishmaniasis is infectious diseases caused by the Leishmania protozoa by the genus Leishmania that present two evolutive ways: one flagellate form, the promastigote, responsabe for infect and a not flagellate form, the amastigote, form in that parasite multiplies at the host. This disease could manifest in three different forms: cutaneous, mucocutaneous or visceral, being the last one th…
(Only some records are available in English at this moment)
Gliosarcoma is a primary malignant tumor and a histopathological variant of wild type glioblastoma multiforme (GBM) isocitrate dehydrogenase (HDI), the rarest and most severe brain tumor. The current standard treatment consists of chemotherapy, radiotherapy and surgical resection of the malignant tissue. However, despite the numerous advances in the techniques, the prognosis remains unfav…
Gliosarcoma is an uncommon histopathological variant of glioblastoma multiforme, highly aggressive, and with unfavorable prognosis, reflecting a survival around months. The treatment consists of the application of surgical resection, radiotherapy, and chemotherapy, however, due to the difficulty of guaranteeing the complete elimination of the tumor and the extensive side effects, it is ne…
Gliosarcoma is a highly agressive malignant neoplasm that affects the Central Nervous System and accounts for 2% of all brain tumors. Despite the advances in conventional treatment techniques, which consist of surgical removal of the lesion, followed by radiotherapy and chemotherapy as secondary treatments, the prognosis of patients with CNS tumors continues to be unfavorable, making it n…
(Only some records are available in English at this moment)
| 5 / 4 | Completed research grants |
| 7 / 6 | Completed scholarships in Brazil |
| 12 / 10 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID